Search for Clinical Trial Results

Sponsored By

Geographic Atrophy - 35 Studies Found

Status Study
Completed Study Name: Evolution and Risk Factors Associated With Geographic Atrophy Progression
Condition: Geographic Atrophy
Date: 2012-09-22
Terminated Study Name: A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
Condition: Geographic Atrophy
Date: 2012-05-18
Interventions:
  • Drug: Al-78898A 0.400 milligra
Withdrawn Study Name: A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy
Condition: Geographic Atrophy
Date: 2010-03-22
Interventions: Drug: RNA-144101 Intravitreous administration of RNA-144101
Active, not recruiting Study Name: Study of of APL-2 Therapy in Patients Geographic Atrophy
Condition: Geographic Atrophy
Date: 2015-07-14
Interventions:
  • Drug: APL-2
  • Other: Sham Procedure
Terminated Study Name: Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy
Condition: Geographic Atrophy
Date: 2012-08-28
Interventions:
  • Drug: Sirolimus Immunosuppress
Completed Study Name: Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Condition: Geographic Atrophy
Date: 2013-01-31
Interventions:
  • Drug: ORACEA® ORACEA®
Active, not recruiting Study Name: CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)
Condition: Geographic Atrophy
Date: 2015-08-03
Interventions:
  • Drug: CLG561
  • Drug: LFG316
Completed Study Name: An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy
Condition: Geographic Atrophy
Date: 2012-05-16
Interventions: Drug: Lampalizumab Lampalizumab 10 mg ITV injections as per the schedule specified in respective arms.
Active, not recruiting Study Name: A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
Condition: Geographic Atrophy
Date: 2014-11-07
Interventions:
  • Other: Sham Sham injection wil
Completed Study Name: A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy
Condition: Geographic Atrophy
Date: 2009-09-08
Interventions: Drug: FCFD4514S Intravitreal escalating dose
Next >>>